Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR

Activating mutations in EGFR predict benefit from tyrosine kinase inhibitor therapy for patients with advanced non-small cell lung cancer. Directing patients to appropriate therapy depends on accurate and timely EGFR assessment in the molecular pathology laboratory. This article describes the analyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Drew F. K., Marris, Sean R. N., Rojas-Rudilla, Vanesa, Bruce, Jacqueline L., Paweletz, Cloud P., Oxnard, Geoffrey R., Sholl, Lynette M., Dong, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870499/
https://www.ncbi.nlm.nih.gov/pubmed/35202431
http://dx.doi.org/10.1371/journal.pone.0264201

Ejemplares similares

Ejemplares similares